261 related articles for article (PubMed ID: 11127311)
1. Outcomes of simultaneous kidney-pancreas transplantation in African-American recipients: a case-control study.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kizilisik AT; Alloway RR; Gaber LW; Gaber AO
Clin Transplant; 2000 Dec; 14(6):572-9. PubMed ID: 11127311
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
Stratta RJ; Alloway RR; Hodge E; Lo A;
Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
[TBL] [Abstract][Full Text] [Related]
3. Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantation.
Lo A; Stratta RJ; Alloway RR; Egidi MF; Shokouh-Amiri MH; Grewal HP; Gaber LW; Gaber AO
Transpl Int; 2001 Dec; 14(6):396-404. PubMed ID: 11793037
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Gruessner RW
Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
[TBL] [Abstract][Full Text] [Related]
5. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression.
Stratta RJ; Shokouh-Amiri MH; Egidi MF; Grewal HP; Lo A; Kizilisik AT; Nezakatgoo N; Gaber LW; Gaber AO
Clin Transplant; 2003; 17 Suppl 9():69-77. PubMed ID: 12795673
[TBL] [Abstract][Full Text] [Related]
6. Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients.
Bruce DS; Sollinger HW; Humar A; Sutherland DE; Light JA; Kaufman DB; Alloway RR; Lo A; Stratta RJ
Transplantation; 2001 Nov; 72(10):1637-43. PubMed ID: 11726823
[TBL] [Abstract][Full Text] [Related]
7. Pancreas transplantation: The Wake Forest experience in the new millennium.
Rogers J; Farney AC; Orlando G; Iskandar SS; Doares W; Gautreaux MD; Kaczmorski S; Reeves-Daniel A; Palanisamy A; Stratta RJ
World J Diabetes; 2014 Dec; 5(6):951-61. PubMed ID: 25512802
[TBL] [Abstract][Full Text] [Related]
8. Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: primary endpoint analysis of a multicenter, randomized study.
Stratta RJ; Alloway RR; Lo A; Hodge E
Transplantation; 2003 Apr; 75(8):1260-6. PubMed ID: 12717213
[TBL] [Abstract][Full Text] [Related]
9. Inferior late functional and metabolic outcomes in African American simultaneous kidney-pancreas recipients.
Rogers J; Stratta RJ; Lo A; Alloway RR
Transplant Proc; 2005 Oct; 37(8):3552-4. PubMed ID: 16298658
[TBL] [Abstract][Full Text] [Related]
10. Effect of ethnicity on outcome of simultaneous pancreas and kidney transplantation.
Rogers J; Baliga PK; Chavin KD; Lin A; Emovon O; Afzal F; Baillie GM; Ashcraft EE; Rajagopalan PR
Am J Transplant; 2003 Oct; 3(10):1278-88. PubMed ID: 14510702
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kisilisik AT; Trofe J; Alloway RR; Gaber LW; Gaber AO
Transpl Infect Dis; 2001 Mar; 3(1):8-15. PubMed ID: 11429034
[TBL] [Abstract][Full Text] [Related]
12. A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy.
Zhang R; Florman S; Devidoss S; Zarifian A; Yau CL; Paramesh A; Killackey M; Alper B; Fonseca V; Slakey D
Am J Transplant; 2007 Jul; 7(7):1815-21. PubMed ID: 17524073
[TBL] [Abstract][Full Text] [Related]
13. African-American ethnicity is no longer a risk factor for early adverse outcomes in simultaneous kidney-pancreas transplantation with contemporary immunosuppression.
Rogers J; Stratta RJ; Alloway RR; Lo A; Hodge EE
Transplant Proc; 2004 May; 36(4):1055-7. PubMed ID: 15194366
[TBL] [Abstract][Full Text] [Related]
14. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.
Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB
Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781
[TBL] [Abstract][Full Text] [Related]
15. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
16. Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction.
Stratta RJ; Gaber AO; Shokouh-Amiri MH; Reddy KS; Alloway RR; Egidi MF; Grewal HP; Gaber LW; Hathaway D
Ann Surg; 1999 May; 229(5):701-8; discussion 709-12. PubMed ID: 10235529
[TBL] [Abstract][Full Text] [Related]
17. Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era.
Hardinger KL; Stratta RJ; Egidi MF; Alloway RR; Shokouh-Amiri MH; Gaber LW; Grewal HP; Honaker MR; Vera S; Gaber AO
Surgery; 2001 Oct; 130(4):738-45; discussion 745-7. PubMed ID: 11602906
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in pancreas transplantation.
Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
[TBL] [Abstract][Full Text] [Related]
19. 5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.
Stratta RJ; Rogers J; Orlando G; Farooq U; Al-Shraideh Y; Farney AC
Transplant Proc; 2014; 46(6):1928-31. PubMed ID: 25131073
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.
Seibert SR; Schladt DP; Wu B; Guan W; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
Clin Transplant; 2018 Dec; 32(12):e13424. PubMed ID: 30318646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
